ArticleScientific reports2025
Gender-specific associations of metabolic and circadian syndromes with melanoma risk: insights from NHANES 2007-2018.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Burden of malignant melanoma among the elderly population in East Asia from 1990 to 2023 and machine learning projection to 2040.PloS one · 2026Article
- Article
- Binational comparison of the association between socioeconomic status and metabolic syndrome: A nationally representative study in South Korea and the United States.Preventive medicine reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
Melanoma incidence is increasing worldwide, prompting exploration into novel risk factors beyond traditional exposures like ultraviolet radiation. Recent studies suggest that metabolic and circadian disruptions may also contribute to melanoma development, yet their influence is poorly understood. This study examines the relationships between metabolic syndrome (MetS), circadian syndrome (CircS) and melanoma risk, emphasizing differences between different genders. Using National Health and Nutrition Examination Survey (NHANES) data (2007-2018), this cross-sectional study applied logistic regression to assess MetS and CircS associations with melanoma risk, adjusting for demographic and lifestyle factors. Receiver operating characteristic curves evaluated predictive ability, and restricted cubic spline models examined dose-response patterns. Among 29,132 participants, 209 reported a melanoma diagnosis. Individuals with MetS or CircS showed a higher melanoma risk. Analysis by gender revealed stronger associations in males than in females. In males, melanoma risk rose sharply when more than two MetS components were present, indicating a dose-response pattern. Additionally, the triglyceride glucose index levels showed more notable predictive value in females than males. MetS and CircS are associated with a higher melanoma risk, with a greater effect of MetS components in males. These findings highlight the potential relevance of metabolic and circadian health in understanding melanoma risk patterns.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.